Old Web
English
Sign In
Acemap
>
Paper
>
Abstract A092: Phase 1 trial of RO6874813, a novel bispecific FAP-DR5 antibody, in patients with solid tumors
Abstract A092: Phase 1 trial of RO6874813, a novel bispecific FAP-DR5 antibody, in patients with solid tumors
2018
Johanna C. Bendell
Jean-Yves Blay
Philippe Cassier
Todd Michael Bauer
Catherine Terret
Claudia Mueller
Anthony Morel
Evelyne Chesne
Zhi Xin Xu
Jean Tessier
Maurizio Ceppi
I. James
Sabine Wilson
Elizabeth Quackenbush
Maria Ochoa de Olza
Josep Tabernero
María de Miguel
Emiliano Calvo
Keywords:
Antibody
Statistics
Cancer research
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]